Solventum Corp (SOLV): Total Liabilities
$9.24B
As of 2025-12-31
$9.44B
As of 2026-06-30
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $9.24B | -19.6% | 2026-02-27, Balance as of period end |
| 2024-12-31 | $11.50B | +405.0% | 2026-02-27, Balance as of period end |
| 2023-12-31 | $2.28B | n/a | 2025-02-28, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Solventum Corp (SOLV) | 2025-12-31 | $9.24B | -19.6% |
| Baxter International Inc (BAX) | 2025-12-31 | $13.95B | -25.6% |
| ResMed Inc (RMD) | 2026-06-30 | $2.38B | +7.9% |
| Dexcom Inc (DXCM) | 2025-12-31 | $3.59B | -18.0% |
| MiniMed Group, Inc. (MMED) | 2026-04-24 | $1.02B | +17.0% |
| West Pharmaceutical Services Inc (WST) | 2025-12-31 | $1.09B | +13.8% |
| Globus Medical Inc (GMED) | 2025-12-31 | $729.51M | -32.1% |
| 3M Co (MMM) | 2025-12-31 | $32.99B | -8.3% |
| Stryker Corp (SYK) | 2025-12-31 | $25.42B | +13.8% |
Compare SOLV, BAX, RMD, DXCM side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗